Translate this page into:
A systematic review comparing the outcomes of utilizing a tricortical screw, quadricortical screw, or suture button for syndesmotic fixation
⁎Corresponding author: Kyle M. Schweser. schweserk@health.missouri.edu
-
Received: ,
Accepted: ,
This article was originally published by Reed Elsevier India Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
Abstract
Abstract
Optimal fixation for distal tibiofibular syndesmotic injuries remains debated, with numerous studies comparing syndesmotic screws (SS) to suture-button (SB) devices. However, limited attention has been given to differentiating tricortical screw (TS) from quadricortical screw (QS) fixation.
To systematically review outcomes of SB, TS, and QS fixation to determine which technique provides superior clinical, radiographic, and patient-reported outcome measures (PROMs), as well as to determine which topics regarding syndesmotic fixation warrant further discussion.
A systematic review was conducted according to a registered PROSPERO protocol. PubMed and Scopus databases were searched using a predefined Boolean equation. Randomized controlled trials (RCTs) and cohort studies with at least 1 year of follow-up and having the SB, SS, TS, or QS as a cohort were included. Data extracted included clinical outcomes, radiographic parameters, and PROMs. Risk of bias was assessed using the RoB-2 for randomized studies and ROBINS-I V2 for cohort studies.
Forty studies (19 RCTs, 21 cohort studies) met inclusion criteria. Most compared SB to SS fixation, while 4 compared TS to QS. Among cohort studies, 11 were classified as having critical risk of bias. Across studies comparing SB and SS, most outcomes were equivalent. Some RCTs demonstrated improved time to weight-bearing, lower reoperation rates, and superior PROMs in the SB group. Comparison between TS and QS fixation showed no significant differences in any clinical, radiographic, or PROM outcomes, although the few studies that met inclusion were of low-quality evidence.
SB fixation may yield marginally improved functional outcomes and reoperation rates compared with SS. The overall evidence remains heterogenous and frequently limited by bias. Studies directly comparing TS to QS is sparse and of insufficient quality, however, there is some belief that TS may be superior. Current gaps in the literature include differentiating which method of fixation is superior in patients with various comorbidities such as diabetes or osteoporosis. Evidence suggests that SB fixation provides comparable or slightly superior outcomes to SS fixation with a lack of evidence to support using a TS or QS. Future studies should focus on the gaps remaining in the literature.
Keywords
Syndesmosis
Syndesmotic
Screw
Suture-button
Tricortical
Quadricortical
Level of evidence: IV
Systematic review
1 Introduction
The most effective option for treatment of the distal tibiofibular syndesmosis has been a highly debated topic, with many systematic reviews with or without a meta-analysis reported frequently in the literature, especially within the past 10 years.1–5 While many individual articles have reported similar outcomes between suture-button (SB) and syndesmotic screw (SS) fixation,6,7 many recent systematic reviews conducted have reported better overall outcomes when using the SB technique for syndesmotic fixation.2–5 The benefits described by these reviews have included fewer reoperation rates, earlier return to sport, and better patient reported outcome measures such as the American Orthopaedic Foot and Ankle Scores (AOFAS) and Foot and Ankle Disability Index (FADI) scores. Many of these reviews, however, include randomized controlled trials containing SS fixation without standardization or specification of how the SS was implanted, with varying use of tricortical screw (TS) and quadricortical screws(QS).3,4,8–10 Utilizing either 3 or 4 cortices for syndesmotic fixation has also been studied as a potential variable to functional outcomes when utilizing a screw for syndesmotic fixation, which would necessitate appropriate separation of these 2 methods in meta-analyses to control for potential confounding variables. Additionally, some studies used 1 syndesmotic screw while others had 2.8,11,12
As with all review articles, bias may arise in the study selection based on predetermined eligibility criteria. With such a large body of literature on the topic of which fixation method is the most appropriate for treatment of syndesmotic injuries, it is important to include only the most relevant articles that appropriately compare the different fixation methods. The purpose of this systematic review is to determine which type of fixation method for injuries of the distal tibiofibular syndesmosis—tricortical screw fixation, quadricortical screw fixation, or suture-button fixation—results in the best overall outcomes for patients by assessing multiple clinical, radiographic, and patient-reported outcome measures (PROMs). While limiting the review to randomized controlled trials would elevate the overall evidence, this review includes cohort studies to further elucidate the conclusions reached by existing evidence regarding the differing fixation methods, rather than reporting on outcomes. A secondary aim focuses on determining the current gaps in the literature regarding fixation methods rather than contributing to the already extensive pool of general comparative outcomes.
2 Methods
2.1 Search strategy and criteria
A predetermined protocol was agreed upon by the authors in the study and registered to the systematic review registry PROSPERO <blinded>(ID: CRD420251003829). We searched for relevant articles that were published up until March 2025 using both the PubMed and SCOPUS medical databases with the following Boolean equation: ((Syndesmosis[Title/Abstract]) OR (Syndesmotic[Title/Abstract])) AND ((fixation[Title/Abstract]) OR (surgical[Title/Abstract]) OR (operative[Title/Abstract])) AND ((screw[Title/Abstract]) OR (suture button[Title/Abstract]) OR (dynamic[Title/Abstract]) OR (flexible[Title/Abstract]) OR (tight rope[Title/Abstract])). Each title and abstract were screened independently by 2 authors <blinded> (BP and CU). The remaining articles then underwent a full-text review to determine eligibility based on the predetermined inclusion/exclusion criteria. All randomized controlled trials and cohort studies with at least 1 of the cohorts being a SB or SS were included if they met the following criteria: Full-text available in English and a minimum 1-year follow up. Exclusion criteria included case-series and case reports, articles that did not have a full-text version available or in English, and cadaveric studies. Additionally, only outcomes that were reported at a minimum of 1 year or greater were reported in the results of this review, with the exception of time to weight-bearing, return to work, and return to sport.
Each of the included studies were screened for the following outcomes: time to weight-bearing, time to return to work, time to return to sport, radiographic outcomes, ankle range of motion, patient reported outcome measures, reoperation rates (reported as unplanned reoperation rates), implant failure, infection, instability, and joint malreduction. Radiographic outcomes included the following: anterior syndesmotic distance (ASD), middle syndesmotic distance (MSD), posterior syndesmotic distance (PSD), syndesmotic area (SA), tibiofibular clear space (TFCS), tibiofibular overlap (TFO), tibiofibular distance (TFD), tibiotalar clear space (TTCS), and fibular rotation (FR). The patient reported outcome measures that were collected are listed in Table 1.
| VAS | RAND-36 | FAOS | PROMIS | AOFAS | FADI | EQ-5D | Other PROMs |
| Pain | Bodily Pain | Symptoms | Pain Intensity | General | General | General | OMS |
| Function | Physical Function | Pain | Pain Interference | Pain | Activities of Daily Living | Index | OTA |
| Activity | General Health | Daily Living | Physical Function | Function | Sport | VAS | SF-36 |
| Pain Rest | Mental Health | Sports and Free Time | Depression | Alignment | UCLA Activity Score | ||
| Pain Walking | Role Function (Physical) | Quality of Life | Gimbry Scale | ||||
| Pain Night | Role Function (Emotional) | ROM | MOXFQ | ||||
| Pain Daily Activity | Vitality | Sports | FAAM Sports | ||||
| Pain Sport | Social Function | ||||||
| Pain Work | |||||||
| Function Sports | |||||||
| Function Work |
2.2 Methodological quality assessment
The Risk of Bias-2 (RoB-2) tool found on the Cochrane's Methods website was used to determine the risk of bias for the randomized controlled trials included in our study. This tool determines bias based on 5 domains. The Risk of Bias in Non-randomized Studies of Interventions version 2 (ROBINS-I V2) assessment tool to determine the risk of bias for each cohort study included in the final review. Similar to the RoB-2, ROBINS-I V2 uses 7 domains to determine the overall risk of bias for non-randomized controlled trials such as cohort studies. One of the domains in the ROBINS-I V2, bias due to confounding, is study specific and based on a predetermined set of variables that the authors deemed to be necessary to control for when considering confounding. While the authors understand that what is and is not confounding is somewhat subjective, the same potential confounders were applied equally to all cohort studies included in this review to allow for an appropriate comparison of bias between studies. The following were considered important confounding variables that were necessary for the original authors of each cohort study to attempt to control for as determined by the authors of this review: demographics, standardization of fixation (versus surgeon preference), postoperative care protocols, and standardized follow-up time.
Additionally, the ROBINS-I V2 tool allows for a preliminary consideration to determine if a complete risk of bias assessment is necessary. This is based on whether the authors made any attempt to control for confounding variables. The studies were deemed to not control for confounding variables if only minimal demographic data was given (such as age and gender being reported) and no statistical analysis was used to determine statistical significance between the 2 groups. Studies that did not pass the preliminary screening were automatically determined to have a critical risk of bias.
3 Results
The results of the search are reported in a Preferred Reporting Items for Systematic Reviews and Meta-analysis study flowchart (Fig. 1). The original search yielded 1840 articles (PubMed: 617; Scopus: 1223) with 1254 articles remaining after duplicates were removed. After title and abstract screening, 86 articles required full-text review to determine eligibility, which ultimately resulted in 40 articles being included in the final review (19 RCTs; 21 cohort studies).

The patient demographics along with risk of bias assessment for each study are outlined in Table 2.
| Author | Design | Comparison | TS vs QS | Follow-Up | Age | BMI | # SB (M:F) | # SS (M:F) | Risk of Bias |
| Wong et al. (2022) 13 | Prospective Cohort of a RCT | SB vs SS | Two TS or QS | 1 year | SB: 46; SS: 37 | N/a | 6 (3:3) | 7 (7:0) | Serious |
| Yawar et al. (2021) 14 | Retrospective Cohort | SB vs SS | US | 1 year | SB: 45; SS: 51 | N/a | 34 (22:12) | 18 (7:13) | Critical |
| Elghazy et al. (2021)15 | Retrospective Cohort | SB vs SS | US | 1 year | SB 44; SS: 43 | SB: 27; SS: 28 | 10 (4:6) | 10 (6:4) | Serious |
| Xu et al. (2022)16 | Retrospective cohort | SB vs SS | TS | 16 months | SB: 34; SS: 39 | N/a | 34 (19:15) | 42 (24:18) | Moderate |
| Gungor et al. (2024)17 | Retrospective Cohort | SB vs SS | US | 27.6 months | 37.3 | N/a | 24 | 24 | Critical |
| Klepacki et al. (2022) 18 | Retrospective Cohort | TS vs QS | TS or QS | 2–4.17 years | TS: 55; QS: 49 | 17–40 | N/a | TS: 17; QS: 38 | Critical |
| Lehtola et al. (2021)7 | RCT | SB vs SS | TS | 7.1 years | 51.7 | N/a | 16 | 17 | Some concerns |
| Altmeppen et al. (2022)19 | RCT | SB vs SS | TS | 10 years | SB: 44; SS: 47 | SB: 28; SS: 28 | 21 (16:5) | 20 (15:5) | Some concerns |
| Lehtola et al. (2022)20 | RCT | NS vs SS | TS | 9.7 years | NS: 45; SS: 43 | N/a | N/a | NS: 11 (7:4); SS: 13 (8:5) | Some concerns |
| Aitor et al. (2022)21 | RCT | SB vs SS | US | 1 year | SB: 41; SS: 49 | N/a | 14 (8:6) | 21 (12:9) | Low |
| Lin et al. (2023)22 | Retrospective Cohort | AAR (Anatomic repair) vs SS | TS | 2 years | AAR: 44; SS: 43 | N/a | N/a | AAR: 30 (16:14); SS: 32 (16:16) | Serious |
| Thornes et al. (2005)23 | Retrospective cohort | SB vs SS | QS | 1 year | SB: 32; SS: 31 | N/a | 16 (13:3) | 16 (12:4) | Critical |
| Kurtoglu et al. (2021)24 | Retrospective Cohort | SB vs SS | QS | 1 year | SB: 37; SS: 41 | N/a | 16 (69.6 % male) | 17 (68.1 % male) | Serious |
| Saraglis et al. (2023)25 | Retrospective Cohort | SB vs SS | US | 1 year | SB: 52; SS: 54 | N/a | 37 (16:21) | 48 (22:26) | Critical |
| Seyhan et al. (2015)26 | Retrospective Cohort | SB vs SS | QS | 1 year | SB: 33; SS: 32 | N/a | 15 (13:2) | 17 (14:3) | Critical |
| Kortekangas et al. (2014)27 | Prospective Cohort of a RCT | NS vs SS | US | 4 years | NS: 45; SS: 43 | N/a | N/a | NS: 11 (7:4); SS: 13 (8:5) | Serious |
| Naqvi et al. (2012)28 | Prospective Cohort | SB vs SS | QS | 2.5 years | SB: 42; SS: 40 | N/a | 23 (17:6) | 23 (16:7) | Critical |
| Colcuc et al. (2017)8 | RCT | SB vs SS | TS | 1 year | SB: 35; SS: 39 | N/a | 26 (19:7) | 28 (22:6) | Low |
| Kortekangas et al. (2015)12 | RCT | SB vs SS | TS | 2 years | SB: 46; SS: 44 | N/a | 21 (13:8) | 22 (14:8) | Some concerns |
| Colcuc et al. (2022)29 | RCT | SB vs SS | TS | 1 year | SB: 32; SS: 39 | N/a | 21 (16:5) | 26 (21:5) | Some Concerns |
| Laflamme et al. (2015)10 | RCT | SB vs SS | QS | 1 year | SB: 40; SS: 39 | SB: 28.6; SS: 28.6 | 34 (25:9) | 36 (26:10) | Low |
| Høiness et al. (2004)30 | RCT | TS vs QS | TS or QS | 1 year | TS:42; QS: 42 | N/a | N/a | TS: 34 (15:19); QS: 30 (17: 13) | Some concerns |
| Wikerøy et al. (2010)31 | Prospective Cohort of a RCT | TS vs QS | TS or QS | 8.7 years | TS: 52; QS: 46 | N/a | N/a | TS: 25 (10:15); QS: 23 (14:9) | Moderate |
| Klepacki et al. (2024)32 | Retrospective Cohort | TS vs QS | TS or QS | 2–4.17 years | TS: 55; QS: 49 | 28 | N/a | TS: 17; QS: 38 | Critical |
| Li et al. (2017)33 | Retrospective Cohort | SB vs SS | TS | 1 year | SB: 42; SS: 40 | N/a | 23 (15:8) | 27 (20:7) | Critical |
| Sanders et al. (2019)34 | RCT | SB vs SS | Two TS | 1 year | SB: 41; SS: 38 | SB: 29; SS: 32 | 50 (77 % male) | 53 (71 % male) | High |
| Zhu et al. (2023)35 | Retrospective Cohort | SB (encircle and binding) vs SS | TS | 15.78 months | SB: 34; SS: 40 | SB: 25.54; SS: 25.3 | 33 (10:23) | 34 (10:24) | Low (PROMs)Serious (Radiographic) |
| Lim et al. (2023)36 | Retrospective Cohort | SB vs SS | TS or QS | 2 years | SB: 35; SS: 35 | SB: 26.8; SS: 27.5 | 30 (20:10) | 28 (19:9) | Moderate |
| Hennings et al. (2022)37 | Retrospective Cohort | SB vs SS | US | 1 year | SB: 39 SS: 55 | N/a | 44 (23:21) | 16 (9:7) | Critical |
| Morales et al. (2022)38 | RCT | SB vs SS | QS | 1 year | SB: 46; SS: 48 | SB: 26.52; SS: 25.98 | 30 (17:13) | 30 (17:13) | Some concerns |
| Raeder et al. (2020)6 | RCT | SB vs SS | TS | 2 years | SB: 44; SS: 48 | SB: 27; SS: 26 | 55 (35:20) | 58 (30: 28) | Low |
| Raeder et al. (2020)39 | RCT | SB vs SS | QS | 5 years | SB: 46; SS: 43 | SB: 27; SS: 27 | 40 | 37 | Low |
| Andersen et al. (2018)9 | RCT | SB vs SS | QS | 2 years | SB 46; SS: 43 | SB: 27; SS: 27 | 48 (34:14) | 49 (30:19) | Some concerns |
| Sun et al. (2014)40 | RCT | BS vs SS | TS | 55.8 months | BS: 39.7; SS: 37.1 | N/a | N/a | BS: 86 (53:33); SS: 82 (45: 37) | Low |
| Kaukonen et al. (2005)41 | RCT | BS vs SS | QS | 35 months | 36 | N/a | N/a | BS: 20; SS: 18 | Low |
| Boyle et al. (2014)42 | RCT | SR vs SS | QS | 1 year | 33.5 | SR: 31; SS: 32 | N/a | SR: 26 (19:7); SS: 25 (16:9) | Some concerns |
| Miller et al. (2010)43 | Prospective Cohort | PM vs SS | QS | 1 year | 48 | N/a | N/a | PM: 9; SS: 14 | Critical |
| Zhan et al. (2016)44 | RCT | AR vs SS | TS | 1 year | AR: 45; SS: 44 | N/a | N/a | AR: 27 (14:13); SS: 26 (12:14) | Some concerns |
| Kocadal et al. (2016) 45 | Retrospective Cohort | SB vs SS | QS | 16.7 months | SB: 43.3; SS: 44.8 | N/a | 26 (16:10) | 26 (17:9) | Serious |
| Xian et al. (2018)46 | RCT | HP vs SS | TS | 1 year | HP: 48; SS: 47 | N/a | N/a | HP: 13 (6:7); SS: 12 (8:4) | High |
Of the 21 cohort studies, 15 directly compared SB to SS fixation, 3 compared TS to QS fixation, 1 compared anatomic repair of the anterior inferior tibiofibular ligament to a SS, 1 compared no screw to SS, and 1 compared posterior malleolar fixation alone to SS fixation. Only the PROMs reported by Zhu et al. were determined to have a minimal risk of bias, 3 studies had a moderate risk of bias, 7 had serious risk of bias, and 10 had a critical risk of bias. For the RCTs, 12 compared SB to SS fixation, 1 study randomized patients to receive either no screw or a SS, 1 compared TS to QS fixation, 2 compared utilizing a bioabsorbable screw to a standard SS, 1 randomized patients to either routine screw removal or a standard SS, 1 randomized patients to either anatomic repair of the AITFL or a SS, and 1 compared the use of a hook plate or SS for syndesmotic fixation. Seven of the RCTS were determined to have a minimal risk of bias, 9 were determined to have “some concern” for risk of bias, and 2 were determined to have a high risk of bias.
Clinical outcomes are reported in Table 3. Fifteen studies reported on ankle range of motion (ROM) with 1 study favoring the SB over the SS for both ankle DF and PF, 1 study favoring the SB for DF alone, 1 study favoring PF alone when comparing anatomic AITFL fixation to SS fixation, and 1 study favoring PF alone when comparing hook plate fixation to SS fixation. Additionally, 1 study favored the use of a biologic screw over a SS for both DF and PF. All 5 studies that reported on time to weightbearing compared SB to SS fixation, 3 of which reported statistical significance favoring the SB. Six studies reported on differences in return-to-work rates. Four of these studies compared SB to SS, with 1 reporting significance. The study comparing AITFL repair to SS found significance in return-to-work rates while the hook plate versus the SS study did not. Three studies compared SB to SS regarding return-to-sport rate with 1 study reporting statistical significance. Of the 15 studies that compared reoperation rates in SB versus SS patients, 3 found a statistically significant difference in favor of the SB. Fourteen studies reported on joint malreduction with 1 study comparing SB to SS reporting statistical significance.
| Author | Time to Weightbear | Return to Work | Return to Sport | Ankle ROM | Reoperation | Implant Failure | Infection | Instability | Joint Malreduction |
| Wong et al.13 | N/a | N/a | N/a | SB: 39; SS: 44 p = 0.37Side to side: SB: 6; SS: 5 p = 0.89 | N/a | N/a | N/a | N/a | N/a |
| Yawar et al.14 | (listed as odds ratio) SB: 1.23. SS: 3.15 p = 0.01 | N/a | N/a | N/a | SB: 11.63 %. SS: 22 % p = 0.09 | N/a | SB: 1; SS: 0 | N/a | N/a |
| Elghazy et al.15 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Xu et al.16 | SB: 6.6; SS: 9.8 p = 0.018 | N/a | N/a | N/a | SB: 8.82 %; SS: 11.9 % | SB: 2; SS: 1 | SB: 1; SS: 0 | N/a | N/a |
| Gungor et al.17 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Klepacki et al.18 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Lehtola et al.7 | N/a | N/a | N/a | N/a | SB: 3; SS: 4 | N/a | SB: 1; SS: 0 | N/a | SB: 1/13; SS: 2/16 p = 0.58 |
| Altmeppen et al.19 | N/a | SB: 9; SS: 11 | SB: 14; SS: 19 p = 0.006 | N/a | N/a | N/a | N/a | N/a | N/a |
| Lehtola et al.20 | N/a | N/a | N/a | NS: 71.6; SS: 68.4 p = 0.512 | NS: 0; SS: 4 | N/a | N/a | N/a | N/a |
| Aitor et al.21 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Lin et al.22 | N/a | N/a | N/a | N/a | N/a | N/a | AR: 0; SS: 1 | N/a | AR: 2; SS: 2 |
| Thornes et al.23 | N/a | SB: 2.8; SS; 4.6 p = 0.02 | N/a | N/a | SB: 0; SS: 12 p = 0.001 | N/a | N/a | N/a | N/a |
| Kurtoglu et al.24 | SB: 8.57; SS: 9.5 p = 0.152 | N/a | N/a | N/a | SB: 0; SS: 3 | N/a | SB: 2; SS: 3 | N/a | N/a |
| Saraglis et al.25 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Seyhan et al.26 | N/a | N/a | N/a | *DF – SB: 1.4; SS: 3.65 p = 0.001; *PF – SB: 2.67; SS: 8.41 p = 0.001 | SB: 2; SS: 4 | N/a | N/a | N/a | N/a |
| Kortekangas et al.27 | N/a | N/a | N/a | NS: 75; SS: 75 | NS: 0; SS: 3 | N/a | N/a | N/a | N/a |
| Naqvi et al.28 | SB: 8; SS: 9.1 p = 0.11 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | SB: 0; SS: 5 p = 0.04 |
| Colcuc et al.8 | N/a | SB: 9; SS: 11 | SB: 14; SS: 19 | N/a | SB: 1; SS: 1 | N/a | SB: 0; SS: 2 | N/a | N/a |
| Kortekangas et al.12 | N/a | N/a | N/a | N/a | SB: 1; SS: 3 | N/a | SB: 1; SS: 0 | N/a | SB: 1; SS: 3 |
| Colcuc et al.29 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Laflamme et al.10 | N/a | SB: 97 %; SS: 87.5 % p = 0.19 | SB: 78.8 %; SS: 68.8 % p = 0.41 | DF – SB: 13.6; SS: 14.8 p = 0.43; PF – SB: 33.6; SS: 32 p = 0.45 | SB: 2; SS: 12 p = 0.006 | SB: 0; SS: 13 | SB 1: SS: 0 | N/a | SB: 4; SS: 0 |
| Høiness et al.30 | N/a | N/a | N/a | *TS: 6.3; QS: 7.6 | TS: 5; QS: 8 | N/a | TS: 1; QS: 5 | N/a | TS: 1; QS: 5 |
| Wikerøy et al.31 | N/a | N/a | N/a | *TS: 5.6; QS: 8 p = 0.22 | N/a | N/a | N/a | N/a | N/a |
| Klepacki et al.32 | N/a | N/a | N/a | DF – TS: 15.5; QS: 15.8; PF – TS: 38.9; QS: 39.2 | N/a | N/a | N/a | N/a | N/a |
| Li et al.33 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | SB: 0; SS: 2 |
| Sanders et al.34 | N/a | N/a | N/a | N/a | SB: 4 %; SS: 15 % p = 0.02 | N/a | SB: 1; SS: 0 | N/a | SB: 1; SS: 1 |
| Zhu et al.35 | SB: 10; SS: 11.1 p = 0.023 | N/a | N/a | N/a | N/a | N/a | SB: 1; SS: 1 | N/a | N/a |
| Lim et al.36 | N/a | N/a | N/a | N/a | SB: 2; SS: 0 | N/a | N/a | N/a | N/a |
| Hennings et al.37 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | SB: 8; SS: 6 p = 0.186 |
| Morales et al.38 | N/a | N/a | N/a | DF – SB: 8.7; SS: 7.5 p = 0.98; PF – SB: 38.7; SS: 38.1 p = 0.85 | SB: 2; SS: 4 | N/a | SB: 2; SS: 0 | N/a | SB: 4; SS: 3 |
| Raeder et al.6 | N/a | N/a | N/a | N/a | SB: 10; SS: 17 p = 0.2 | N/a | N/a | N/a | SB: 3; SS: 3 |
| Raeder et al.39 | N/a | N/a | N/a | *DF – SB: 4; SS: 8.1 p = 0.025; PF – SB: 6.3; SS: 6.0 p = 0.905 | N/a | N/a | N/a | N/a | N/a |
| Andersen et al.9 | N/a | N/a | N/a | N/a | SB: 15; SS: 15 | N/a | SB: 2; SS: 2 | N/a | SB: 0; SS: 1 |
| Sun et al.40 | N/a | N/a | N/a | DF – BS: 22; SS: 18; p = 0.011 PF – BS: 40; SS: 35 p = 0.001 | BS: 5; SS: 0 | N/a | N/a | N/a | N/a |
| Kaukonen et al.41 | N/a | N/a | N/a | DF – BS: 22.2; SS: 25.2; PF – BS: 45.9; SS: 45.4 | BS: 2; SS: 1 | N/a | BS: 0; SS: 1 | N/a | N/a |
| Boyle et al.42 | N/a | N/a | N/a | DF – SR: 13; SS: 10.2 p = 0.194; PF – SR: 31.2; SS: 33.6 p = 0.503 | SR: 3; SS: 1 | N/a | SR: 1; SS: 0 | N/a | N/a |
| Miller et al.43 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Zhan et al.44 | N/a | AR: 5.26; SS: 7.15 p = 0.02 (months) | N/a | DF – AR: 15.0; SS: 14.4 p = 0.56; PF – AR: 34.3; SS: 31.2 p = 0.043 | N/a | AR: 0; SS: 3 | AR: 1; SS: 1 | N/a | AR: 2; SS: 5 |
| Kocadal et al.45 | N/a | N/a | N/a | N/a | SB: 1; SS: 10 | N/a | SB: 1; SS: 0 | N/a | N/a |
| Xian et al.46 | N/a | HP: 7.31; SS: 9.25 (months) | N/a | DF – HP: 14.7; SS: 12.8 p = 0.16; PF – HP: 35.2; SS: 30.3 p = 0.04 | N/a | N/a | HP: 0; SS: 1 | N/a | HP: 1; SS: 3 |
Radiographic outcomes are reported in Table 4. Of the 5 studies that reported on anterior syndesmotic distance, 2 demonstrated results that were significant favoring the SB over the SS. One study demonstrated statistical significance between middle syndesmotic distance. For the studies that reported on syndesmotic area, 1 study demonstrated that both the SB and SS had a statistically significant difference in syndesmotic area when the operated ankle was compared to the healthy ankle. The study by Kocadal et al.45 demonstrated a statistically significant difference between the upper syndesmotic area when comparing healthy and operated ankles in the SS group as well as a significant difference between the healthy and operated ankles for the lower syndesmotic area in the SB group. Two of the 8 studies that looked at the tibiofibular clear space between SB and SS demonstrated a statistically significant difference, while the other 6 did not. Only 1 of the 9 studies looking at tibiofibular overlap demonstrated a significant difference between the SB and SS groups. Only 2 studies looked at tibiofibular distance. The study that compared TS to QS found no significant difference; however, the study that compared SB to SS did find a significant difference. Klepacki et al.18 found a significant difference in medial clear space when comparing TS to QS fixation, while none of the SB vs SS studies found any difference. Three of the 4 studies that compared SB to SS regarding fibular rotation found a significant difference between the 2 groups that favored the SB.
| Author | How? | ASD | MSD | PSD | SA | TFCS | TFO | TFD | TTCS | MCS | FR |
| Wong et al.13 | Syndesmotic Position in Neutral Dorsiflexion | SB: 4.5; SS: 4.2 | SB: 4.0; SS: 4.1 | SB: 6.3; SS: 6.9 | SB: 136; SS: 164 | SB: 4.2; SS: 4.6 | SB: −0.6; SS: −0.1 | SB: 11.8; SS: 13.9 | |||
| Yawar et al.14 | NS | N/a | N/a | N/a | N/a | N/a | SB: 7.68; SS: 3.57 p = 0.21 | N/a | N/a | SB: 3.18; SS: 3.57 p = 0.19 | N/a |
| Elghazy et al.15 | Operated vs healthy | SB: 1.7 p = 0.025; SS: 1.57 p = 0.2 | SB: 0.67 p = 0.4; SS: 1.11 p = 0.1 | SB: −0.41 p = 0.99; SS: 1.15 p = 0.3 | SB: 27.99 p = 0.003; SS: 40.9 p = 0.006 | N/a | N/a | N/a | N/a | N/a | SB: −7.77 p = 0.004; SS: −5.16 p = 0.4 |
| Xu et al.16 | Compared to standard values | N/a | N/a | N/a | N/a | SB: 3.8; SS: 3.6 p = 0.238 | SB: 8.8; SS: 8.2 p = 0.148 | N/a | N/a | N/a | N/a |
| Gungor et al.17 | Listed as preop - postop | N/a | N/a | N/a | N/a | SB: 7.3-5.1; SS: 7.2-4.8 | SB: 4.9–7.9; SS: 4.9–7.8 | N/a | N/a | SB: 7.7-4.3; SS: 7.9-4.3 | N/a |
| Klepacki et al.18 | Compared to standard values | N/a | N/a | N/a | N/a | N/a | TS: 7.01; QS: 8.26 p = 0.13 | TS: 4.04; QS: 4.09 p = 0.93 | N/a | TS: 2.84; QS: 3.5 p = 0.005 | N/a |
| Lehtola et al.7 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Altmeppen et al.19 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Lehtola et al.20 | N/a | N/a | N/a | N/a | N/a | NS: 6.1; SS: 5.0 p = 0.174 | N/a | N/a | NS: 3.3; SS: 2.8 p = 0.077 | N/a | N/a |
| Aitor et al.21 | Difference in healthy and operated ankle | SB: 2.4; SS: 5.5 p = 0.51 | N/a | SB: −3; SS: −5.5 p = 0.57 | N/a | N/a | N/a | N/a | N/a | N/a | SB: −2.4; SS: −4.8 p = 0.023 |
| Lin et al.22 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Thornes et al.23 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Kurtoglu et al.24 | Compared to standard values | N/a | N/a | N/a | N/a | SB: 4.6; SS: 5.9 p < 0.001 | SB: 6.9; SS: 5.8 p = 0.03 | N/a | N/a | SB: 3.1; SS: 3.4 p = 0.121 | N/a |
| Saraglis et al.25 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Seyhan et al.26 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Kortekangas et al.27 | Compared to standard values | N/a | N/a | N/a | N/a | NS: 5.9; SS: 5.5 p = 0.83 | N/a | N/a | NS: 2.9; SS: 2.8 p = 0.62 | N/a | N/a |
| Naqvi et al.28 | Operated compared to healthy | N/a | N/a | N/a | N/a | N/a | N/a | SBO: 4.37; SBH: 4.04 p = 0.3; SSO: 5.16; SSH: 4.02 p = 0.01 | N/a | N/a | N/a |
| Colcuc et al.8 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Kortekangas et al.12 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Colcuc et al.29 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Laflamme et al.10 | Compared to standard values | N/a | N/a | N/a | N/a | SB: 3.9; SS: 4.8 p = 0.008 | N/a | N/a | N/a | SB: 2.9; SS: 3.1 p = 0.38 | N/a |
| Høiness et al.30 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Wikerøy et al.31 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Klepacki et al.32 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Li et al.33 | Compared to standard values | N/a | N/a | N/a | N/a | SB: 4.4; SS: 4.1 P = 0.084 | SB: 7.8; SS: 8.9 P = 0.168 | N/a | N/a | SB: 3.3; SS: 3.1 P = 0.192 | N/a |
| Sanders et al.34 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Zhu et al.35 | Compared to standard values | N/a | N/a | N/a | N/a | SB: 3.95; SS: 3.88 p = 0.696 | SB: 8.22; SS: 8.21 p = 0.947 | N/a | N/a | N/a | N/a |
| Lim et al.36 | Compared to standard values | N/a | N/a | N/a | N/a | SB: 4.5; SS: 4.8 p = 0.116 | SB: 6.3; SS: 6.2 p = 0.848 | N/a | N/a | SB: 2.7; SS: 2.9 p = 0.399 | N/a |
| Hennings et al.37 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Morales et al.38 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Raeder et al.6 | Difference b/w injured and healthy | SB: 0.9; SS: 0.7 p = 0.5 | SB: 1.4; SS: 1 p = 0.2 | SB: 0; SS: 0.3 p = 0.4 | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Raeder et al.39 | Difference b/w injured and healthy | SB: −0.1; SS: 1.2 p = 0.016 | SB: 0.5; SS: 1 p = 0.413 | SB: −0.1; SS: −0.1 p = 0.952 | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Andersen et al.9 | Calculated as difference in healthy vs operated | SB: 0.8; SS: 2.0 p = 0.006 | SB: 0.7; SS: 1.5 p = 0.01 | SB: 0.6; SS: 1.0 p = 0.22 | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Sun et al.40 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Kaukonen et al.41 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Boyle et al.42 | Compared to standard values | N/a | N/a | N/a | N/a | SR: 5.3; SS: 5.0 p = 0.276 | N/a | N/a | N/a | N/a | N/a |
| Miller et al.43 | Compared to standard values | N/a | N/a | N/a | N/a | PM: 4; SS: 4.3 | PM: 6.2; SS: 7.2 | N/a | N/a | PM: 2.9; SS: 3.2 | N/a |
| Zhan et al.44 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Kocadal et al.45 | Operated compared to healthy | N/a | N/a | N/a | USA (SBO: 88.9; SBH: 81.8 p = 0.1; SSO: 99; SSH: 84.5 p = 0.006) MSA (SBO: 79; SBH: 75.7 p = 0.3; SSO: 86.2; SSH: 84.3 p = 0.7) LSA (SBO: 73.2; SBH: 64.1 p = 0.02; SSO: 71.5; SSH: 70.8 p = 0.8) | N/a | N/a | N/a | N/a | N/a | SBO: 14.4; SBH: 12.3 p = 0.1; SSO: 10.9; SSH: 14.2 p = 0.03 |
| Xian et al.46 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
Patient reported outcome measures are provided in Table 5. Of the 40 studies included, 33 studies reported PROMs across a wide variety of scoring systems. The most commonly used PROMs were the Olerud Molander Ankle Score (OMS) and the American Orthopaedic Foot and Ankle Score (AOFAS). With regard to the OMS score, 2 of the 12 studies that compared SB to SS found statistical significance in favor of the SB.10,39 Fifteen SB vs SS studies used the AOFAS score with only 2 finding a significant difference in favor of the SB.23,39 For studies that used the VAS pain system, 1 of 6 studies favored the SB.17 No studies comparing TS to QS showed any significant difference in any of the PROMs.
| Author | PROMIS Pain Intensity | PROMIS Pain Interference | PROMIS Physical Function | PROMIS Depression | OMS | AOFAS | VAS Pain | VAS Function | FADI |
| Wong et al.13 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Yawar et al.14 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Elghazy et al.15 | SB: 30.7; SS: 33.25 p = 0.3 | SB: 38.7; SS: 38.7 p = 0.4 | SB: 57.35; SS: 53.35 p = 0.3 | SB: 37; SS: 45.7 p = 0.2 | N/a | N/a | N/a | N/a | N/a |
| Xu et al.16 | N/a | N/a | N/a | N/a | SB: 91.1; SS: 90.6 p = 0.104 | N/a | N/a | N/a | N/a |
| Gungor et al.17 | N/a | N/a | N/a | N/a | SB: 85.1; SS: 84.5 p = 0.746 | SB: 86; SS: 89 p = 0.722 | SB: 1; SS: 2 p = 0.02 | N/a | SB: 86.8; SS: 85.4 p = 0.14 |
| Klepacki et al.18 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Lehtola et al.7 | N/a | N/a | N/a | N/a | SB: 78; SS: 88 p = 0.32 | N/a | N/a | N/a | N/a |
| Altmeppen et al.19 | N/a | N/a | N/a | N/a | SB: 98.81; SS: 93 p = 0.10 | SB: 91; SS: 91 | N/a | N/a | N/a |
| Lehtola et al.20 | N/a | N/a | N/a | N/a | NS: 89; SS: 87.3 p = 0.767 | N/a | NS: 12.2; SS: 10.5 | NS: 14.6; SS: 16.2 | N/a |
| Aitor et al.21 | N/a | N/a | N/a | N/a | N/a | SB: 91.8; SS: 92.8 p = 0.927 | N/a | N/a | N/a |
| Lin et al.22 | N/a | N/a | N/a | N/a | AR: 97.2; SS: 95.7 p = 0.123 | AR: 95.6; SS: 94.2 p = 0.094 | AR: 0.4; SS: 0.6 p = 0.173 | N/a | N/a |
| Thornes et al.23 | N/a | N/a | N/a | N/a | N/a | SB: 93; SS: 83 p = 0.04 | N/a | N/a | N/a |
| Kurtoglu et al.24 | N/a | N/a | N/a | N/a | N/a | SB: 86; SS: 84 | N/a | N/a | SB: 79; SS: 77 |
| Saraglis et al.25 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Seyhan et al.26 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Kortekangas et al.27 | N/a | N/a | N/a | N/a | NS: 93; SS: 81 p = 0.116 | N/a | NS: 4; SS: 11 p = 0.56 | NS: 6; SS: 12 p = 0.193 | N/a |
| Naqvi et al.28 | N/a | N/a | N/a | N/a | N/a | SB: 89.56; SS: 86.52 p = 0.26 | N/a | N/a | SB: 82.42; SS: 81.22 p = 0.76 |
| Colcuc et al.8 | N/a | N/a | N/a | N/a | SB: 93; SS: 90 | SB: 91; SS: 91 | N/a | N/a | N/a |
| Kortekangas et al.12 | N/a | N/a | N/a | N/a | SB: 82; SS: 84 | N/a | SB: 12; SS: 12 | SB: 15; SS: 11 | N/a |
| Colcuc et al.29 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Laflamme et al.10 | N/a | N/a | N/a | N/a | SB: 93.3; SS: 76.9 p = 0.046 | SB: 93.1; SS: 89.9 p = 0.255 | SB: 0.6; SS: 1.1 p = 0.12 | N/a | N/a |
| Høiness et al.30 | N/a | N/a | N/a | N/a | TS: 88.8; QS: 83.3 | N/a | N/a | N/a | N/a |
| Wikerøy et al.31 | N/a | N/a | N/a | N/a | TS: 82.3; QS: 82.8 p = 0.9 | N/a | TS: 4.9; QS: 4.5 p = 0.8 | N/a | N/a |
| Klepacki et al.32 | N/a | N/a | N/a | N/a | N/a | TS: 76.17; QS: 75.13 | TS: 4; QS: 3.78 | N/a | N/a |
| Li et al.33 | N/a | N/a | N/a | N/a | N/a | SB: 85.7; SS: 83.6 p = 0.79 | N/a | N/a | SB: 81.9; SS: 82.3 p = 0.341 |
| Sanders et al.34 | N/a | N/a | N/a | N/a | SB: 84.9; SS: 80 p = 0.25 | N/a | N/a | N/a | SB: 93.1; SS: 89.6 p = 0.18 |
| Zhu et al.35 | N/a | N/a | N/a | N/a | N/a | SB: 95.33; SS: 92.7 p = 0.064 | SB: 0.94; SS: 1 p = 0.753 | N/a | N/a |
| Lim et al.36 | N/a | N/a | N/a | N/a | SB: 95.2; SS: 90.5 p = 0.78 | SB: 93.5; SS: 88.0 p = 0.85 | SB: 0.7; SS: 1.1 p = 0.73 | N/a | N/a |
| Hennings et al.37 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Morales et al.38 | N/a | N/a | N/a | N/a | SB: 90; SS: 92.67 | SB: 92.10; SS: 93.03 | SB: 1.93; SS: 1.85 | N/a | N/a |
| Raeder et al.6 | N/a | N/a | N/a | N/a | SB: 90; SS: 100 p = 0.2 | SB: 97; SS: 97 p = 0.7 | N/a | N/a | N/a |
| Raeder et al.39 | N/a | N/a | N/a | N/a | SB: 100; SS: 95 p = 0.006 | SB: 100; SS: 90 p = 0.006 | N/a | N/a | N/a |
| Andersen et al.9 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Sun et al.40 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Kaukonen et al.41 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Boyle et al.42 | N/a | N/a | N/a | N/a | SR: 86.7; SS: 82.4 p = 0.367 | SR: 90.1; SS: 88.6 p = 0.688 | SR: 0.66; SS: 1.03 p = 0.237 | N/a | N/a |
| Miller et al.43 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Zhan et al.44 | N/a | N/a | N/a | N/a | AR: 90.37; SS: 85.77 p = 0.096 | N/a | AR: 0.81; SS: 1.08 p = 0.34 | N/a | N/a |
| Kocadal et al.45 | N/a | N/a | N/a | N/a | N/a | SB: 88.4; SS: 86.1 p = 0.4 | N/a | N/a | N/a |
| Xian et al.46 | N/a | N/a | N/a | N/a | N/a | N/a | HP: 1.46; SS: 2.42 p = 0.3 | N/a | N/a |
| Author | RAND-36 Bodily Pain | RAND-36 Physical Function | RAND-36 General Health | RAND-36 Mental Health | RAND-36 Role Function (Physical) | RAND-36 Vitality | RAND-36 Social Function | RAND-36 Role Function (Emotional) |
| Lehtola et al.7 | SB: 73; SS: 83 p = 0.24 | SB: 78; SS: 86 p = 0.54 | SB: 69; SS: 73 p = 0.64 | SB: 82; SS: 81 p = 0.88 | SB: 73; SS: 73 p = 0.87 | SB: 70; SS: 75 p = 0.56 | SB: 85; SS: 87 p = 0.89 | SB: 88; SS: 79 p = 0.46 |
| Lehtola et al.20 | NS: 85; SS: 69.8 p = 0.085 | NS: 89.5; SS: 84.6 p = 0.478 | N/a | N/a | N/a | N/a | N/a | N/a |
| Kortekangas et al.27 | NS: 89; SS: 78 p = 0.59 | NS: 92; SS: 86 p = 0.186 | N/a | N/a | N/a | N/a | N/a | N/a |
| Kortekangas et al.12 | SB: 78; SS: 76 | SB: 87; SS: 77 | SB: 72; SS: 69 | SB; 87; SS: 77 | SB: 85; SS: 80 | SB: 73; SS: 69 | SB: 89; SS: 86 | SB: 89; SS: 83 |
| Author | AOFAS Pain | AOFAS Function | AOFAS Alignment | AOFAS Total | OTA | SF-36 | UCLA | Gimbry Scale | VAS Activity | EQ-5D | EQ-5D Index | EQ-5D VAS | MOXFQ |
| Seyhan26 | SB: 38; SS: 38.23 p = 0.87 | SB: 45.93; SS: 45.29 p = 0.653 | SB: 10; SS: 10 p = 1 | SB: 93.73; SS: 93.35 p = 0.889 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Wikeroy et al.31 | N/a | N/a | N/a | N/a | TS: 88.5; QS: 84.3 p = 0.2 | TS: 103.8; QS: 101.5 p = 0.41 | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Klepacki et al.32 | N/a | N/a | N/a | N/a | N/a | N/a | TS: 5.71; QS: 5.82 | TS: 3.64; QS: 3.71 | TS: 5.64; QS: 6.02 | N/a | N/a | N/a | N/a |
| Sanders et al.34 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | SB: 0.88; SS: 0.91 p = 0.45 | N/a | N/a | N/a |
| Raeder et al.6 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | SB: 1; SS: 1 p = 0.3 | SB: 85; SS: 90 p = 0.6 | SB: 5; SS: 3 p = 0.2 |
| Raeder et al.39 | SB: 1; SS: 1 p = 0.613 | SB: 80; SS: 85 p = 0.682 |
| Author | FADI ADL | FADI Sport | VAS Pain Rest | VAS Pain Walking | VAS Pain Night | VAS Pain Daily Activity | VAS Pain Sports | VAS Pain Work | VAS Function Sports | VAS Function Work | FAAM Sports |
| Altmeppen et al.19 | SB: 99.22; SS: 95.86 p = 0.154 | SB: 97.03; SS: 91.10 p = 0.254 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Colcuc et al.8 | SB: 94; SS: 96 | SB: 81; SS: 87 | N/a | N/a | N/a | N/a | SB: 2; SS: 1 | SB: 1; SS: 1 | SB: 2; SS: 2 | SB: 1; SS: 1 | N/a |
| Colcuc et al.29 | N/a | SB: 87; SS; 86 | N/a | N/a | N/a | N/a | SB: 2; SS: 1 | N/a | SB: 2; SS: 2 | N/a | SB: 89; SS: 85 |
| Sanders et al.34 | N/a | SB: 80.5; SS: 70.8 p = 0.07 | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a | N/a |
| Raeder et al.6 | N/a | N/a | SB: 0; SS: 0 p = 0.6 | SB: 0; SS: 0 p = 0.2 | SB: 0; SS: 0 p = 0.2 | SB: 0; SS: 0 p = 0.3 | N/a | N/a | N/a | N/a | N/a |
| Raeder et al.39 | N/a | N/a | SB: 0; SS: 0 | SB: 0; SS: 0 | SB: 0; SS: 0 | SB: 0; SS: 0 | N/a | N/a | N/a | N/a | N/a |
| Author | FAOS Symptoms | FAOS Pain | FAOS Daily Living | FAOS Sports and Free Time | FAOS Quality of Life | FAOS ROM | FAOS Sports |
| Kortekangas et al.12 | SB: 81; SS: 78 | SB: 92; SS: 89 | SB: 93; SS: 94 | SB: 85; SS: 82 | SB: 78; SS: 78 | SB: 83; SS: 82 | N/a |
| Miller et al.43 | PM: 73; SS: 72 | PM: 76; SS: 78 | PM: 84; SS: 79 | N/a | PM: 56; SS: 58 | N/a | PM: 65; SS: 76 |
4 Discussion
This systematic review on syndesmotic fixation consolidates the extensive literature on the topic to determine the gaps that necessitate further study. Many studies found equivalent outcomes between the SB and SS, however, of those that demonstrated a significant difference, favored the SB. Only 1 study reported a statistically significant finding in favor of the SS regarding lower syndesmotic area.45 However, this study was classified as having a serious risk of bias. This 1 radiographic parameter did not appear to correlate clinically, as none of the clinical outcomes or PROMs demonstrated a statistical significance in this study. Regarding TS vs QS, 1 study found a difference in MCS, but no other outcomes were significant when deciding to use a TS or QS.18 Additionally, this study was determined to be at critical risk of bias.
A strength of this review regards the quality assessment and number of studies examining outcomes comparing SB to SS, with the majority at serious or critical risk of bias. While oftentimes it is necessary to publish on preliminary results in the literature to justify future, higher quality studies, 11 of the 21 published cohort studies were determined to be at a critical risk of bias, 8 of which were direct comparisons of SB to SS. While the preliminary determination of confounding variables is somewhat subjective when using the ROBINS-I V2 tool (as outlined in the Methods section), it is essential across all studies for authors to try to control for confounding variables by providing demographic data and providing the appropriate information to determine if there was any significant difference in the demographics of the 2 populations being studied. Six of the 21 cohort studies had serious risk of bias. This left only 4 cohort studies that were moderate or minimal risk of bias. Of the RCTs included in this study, only 2 of the 19 studies were at a high risk of bias, with the remaining being either low (7) or having some concerns (10). Oftentimes, studies were classified as having “some concerns” due to the lack of blinding, which may inherently lead to a level of expectancy bias. Based on the extensive literature, future studies are no longer warranted when looking at general outcomes between a SB and SS in the general population.
On the other hand, only 4 studies that compared TS to QS fixation satisfied the eligibility criteria of this systematic review. Three of these were cohort studies (2 of which had critical risk of bias) and 1 was a RCT. Only 1 study demonstrated a significant difference between TS and QS fixation, and it was at a critical risk of bias. Thus, the literature is lacking regarding high quality studies reporting on outcomes between the use of TS or QS fixation. More high-quality studies examining TS and QS fixation are warranted. If a difference is demonstrated between the 2, this would then necessitate future RCTs comparing SB to SS using either TS or QS for the respective fixation method. Many RCTs in this review stated in the methods that a combination of both TS and QS were utilized in their studies while some specified that either a single TS or QS was used. These studies were then included in subsequent meta-analysis that have been reported in the literature.2–4
An interesting finding in this review is that when the RCTs were split between SB vs. TS or SB vs. QS, based on the method of screw fixation outlined by the authors in their respective methods section, only 1 study included in this review found a significant difference between using a SB and a SS if it was specified that a TS was used. Altmeppen et al. performed a RCT with a 10-year follow-up comparing the SB to a SS, where they specified in their methods that a single TS was used for their SS group.19 Their study consisted of 21 patients in the SB group and 20 in the SS group. They found that patients in the SB group had a return to sport time that was superior to the SS group (14 weeks versus 19 weeks). Although the patients in the SB group had a return to sport time that was greater, this result did not have any correlation to any of the PROMs, including the FADI sport score. All other RCTs that compared SB to SS and specified using a TS for their SS group demonstrated no significant difference in any clinical, radiographic, or PROMs.6,7,27,29 On the other hand, studies that examined SB versus SS that specified using a QS consistently found that SB was superior to the SS group in all but 1 study. Laflamme et al. reported a higher reoperation rate, improved reduction as measured on plain radiographs regarding the TFCS, and better OMS scores in the SB group.10 Raeder et al. found that their SB group had better postoperative ROM and better OMS and AOFAS scores.39 Andersen et al. also found that the SB group had better maintenance of radiographic reduction compared to their SS group.9 Morales et al. was the only RCT that specified using a QS in their methods that found no significant difference between their SB or SS groups.38 While it would be inappropriate to draw any conclusions considering the design of these studies focused on SS versus SB—they did not specifically look at using a TS or QS—these findings suggest that the use of a TS may be more beneficial than the use of a QS and future studies are warranted.
Previous meta-analysis have reported better outcomes for use of the SB compared to the SS.4,9,34 Shimozono et al. performed a meta-analysis that included 5 RCTs. Their results demonstrated that the use of the SB was superior to the SS due to superior functional outcomes and lower rates of broken implants and joint malreduction.4 As explained in their review, joint malreduction or loss of reduction is negatively associated with clinical outcomes. It has long been understood that malreduction of the ankle syndesmosis leads to decreased contact area and an increase in peak pressures across the ankle joint.47–49 While many studies in this review did not necessarily demonstrate a correlation between radiographic and clinical outcomes, many of these studies were limited to 1–2 years follow-up. It can be assumed reasonably based on previous literature that these studies would show worse outcomes in the patients with malreduced joints if the follow-up period were to be extended to 10 or more years post-operative.
While the topic of SB versus SS has been well studied regarding outcomes in general populations, there is justification to compare outcomes of the 2 fixation techniques based on certain patient populations or injury types. Multiple studies examined the use of SB versus SS in specific types of ankle fractures, some of which were included in this review.7,20,27,36 Another important consideration when deciding which type of fixation method to use would be patient comorbidities or BMI. While most studies used patient age, comorbidities, BMI, and associated injuries as exclusion criteria, this review found no studies comparing outcomes between SB and SS or TS vs QS in specific patient populations such as diabetic patients, osteoporotic patients, elderly patients, or patients over a certain BMI that met our inclusion criteria. The use of trans-syndesmotic screw fixation has been described to be of benefit in diabetic patients or patients with osteoporotic bone, however, the authors could not find any long-term studies comparing outcomes between the SB or SS in these patient populations.50 One study performed by Black et al. compared radiographic outcomes of the SB and SS across various BMIs in 79 patients.51 The results of this study were not included in our final analysis as the average follow-up was less than 1 year (5.5 months). Their results demonstrated that both the SB and SS demonstrated similar results across all BMIs, supporting the use of both the SB and SS in overweight and obese patients.51 Future studies should investigate these specific areas to determine if certain patient demographic factors or comorbidities should play a role in deciding which method of syndesmotic fixation will provide the best outcomes in certain patient populations.
There are certain limitations and potential bias of this study that should be considered. The first reason is that this review was limited to only the PubMed and Scopus databases. Another limitation is that this review included both RCTs and cohort studies, leading to a heterogeneity of results. While this makes our study a lower level of evidence, this was necessary to achieve our goal of determining current gaps in the literature. Additionally, the use of the RoB-2 and ROBINS-I V2 adds transparency to which studies are of higher quality evidence and which are not. There is also the inherent nature of publication bias that may limit many studies that did not demonstrate a difference between certain fixation techniques from being published.
5 Conclusion
The use of SS or SB fixation for syndesmotic disruption has been extensively studied in the general population, and the majority demonstrates no difference between them. However, of those that demonstrated a significant difference, all but 1 study found that SB is superior for faster return to sports, better radiographic outcomes, and better PROMs. Direct comparison of a TS and a QS has also, in general, shown equivalent outcomes. However, this particular subtopic has received very limited attention in the literature. Based on the limited literature, a TS may result in superior outcomes compared to the QS. Thus, these methods of screw fixation should be separated when comparing the SB to the SS for syndesmotic fixation. Future studies should focus on the gaps that remain when determining which method of syndesmotic fixation is superior, including RCTs comparing the SB vs. the SS in specific patient populations, and directly comparing QS and TS to SB.
Guardian/patient's consent
Consent for minors was not needed for this study.
Ethical statement
University of Missouri Institutional Review Board approval was not needed to conduct this systematic review.
Credit author statement
Conceptualization: B.A.P., C.U., J.L.C., and K.M.S.; Formal analysis: B.A.P., C.U., J.L.C., and K.M.S.; Investigation: B.A.P., C.U., J.L.C., and K.M.S.; Surgical expertise: J.L.C. and K.M.S. Resources: J.L.C. and K.M.S.; Supervision: J.L.C. and K.M.C.; Writing – original draft: B.A.P., C.U., J.L.C., and K.M.S.; Writing – review & editing: B.A.P., C.U., J.L.C., and K.M.S.
Funding statement
No funding from an external source was needed to conduct this study.
References
- A systematic review of suture-button versus syndesmotic screw in the treatment of distal tibiofibular syndesmosis injury. BMC Musculoskelet Disord. 2017;18:1-12.
- [Google Scholar]
- Comparison of suture button fixation and syndesmotic screw fixation in the treatment of distal tibiofibular syndesmosis injury: a systematic review and meta-analysis. Int J Surg. 2018;60:120-131.
- [Google Scholar]
- Comparison of suture-button versus syndesmotic screw in the treatment of distal tibiofibular syndesmosis injury: a meta-analysis. J Foot Ankle Surg. 2021;60:555-566.
- [Google Scholar]
- Suture button versus syndesmotic screw for syndesmosis injuries: a meta-analysis of randomized controlled trials. Am J Sports Med. 2019;47:2764-2771.
- [Google Scholar]
- Syndesmotic stabilization: syndesmotic screw versus flexible fixation: a systematic review. J Foot Ankle Surg. 2021;60:998-1007.
- [Google Scholar]
- Randomized trial comparing suture button with single 3.5 mm syndesmotic screw for ankle syndesmosis injury: similar results at 2 years. Acta Orthop. 2020;91:770-775.
- [Google Scholar]
- Suture button versus syndesmosis screw fixation in pronation-external rotation ankle fractures: a minimum 6-year follow-up of a randomised controlled trial. Injury. 2021;52:3143-3149.
- [Google Scholar]
- Lower complication rate and faster return to sports in patients with acute syndesmotic rupture treated with a new knotless suture button device. Knee Surg Sports Traumatol Arthrosc. 2018;26:3156-3164.
- [Google Scholar]
- Randomized trial comparing suture button with single syndesmotic screw for syndesmosis injury. J Bone Joint Surg Am. 2018;100:2-12.
- [Google Scholar]
- A prospective randomized multicenter trial comparing clinical outcomes of patients treated surgically with a static or dynamic implant for acute ankle syndesmosis rupture. J Orthop Trauma. 2015;29:216-223.
- [Google Scholar]
- Treatment of syndesmoses disruptions: a prospective, randomized study comparing conventional screw fixation vs TightRope fiber wire fixation - medium term results. SA Orthop J. 2009;8:32-37.
- [Google Scholar]
- A prospective randomised study comparing TightRope and syndesmotic screw fixation for accuracy and maintenance of syndesmotic reduction assessed with bilateral computed tomography. Injury. 2015;46:1119-1126.
- [Google Scholar]
- In vivo syndesmotic motion after rigid and flexible fixation using 4-dimensional computerized tomography. J Orthop Trauma. 2022;36:257-264.
- [Google Scholar]
- Suture-button versus syndesmotic screw fixation of ankle fractures: a comparative retrospective review over one year. Cureus. 2021;13
- [Google Scholar]
- Screw versus suture button in treatment of syndesmosis instability: Comparison using weightbearing CT scan. Foot Ankle Surg. 2021;27:285-290.
- [Google Scholar]
- The clinical efficacy of suture-button fixation and trans-syndesmotic screw fixation in the treatment of ankle fracture combined with distal tibiofibular syndesmosis injury: a retrospective study. J Foot Ankle Surg. 2022;61:143-148.
- [Google Scholar]
- Comparison of screw fixation and dynamic fixation in the treatment of ankle fractures with syndesmotic ruptures. Ulus Travma Acil Cerrahi Derg. 2024;30:900-906.
- [Google Scholar]
- Radiographic assessment of tibiofibular syndesmosis injury with different durations and types of fixation. J Clin Med. 2022;11:6331.
- [Google Scholar]
- A 10-year follow-up of ankle syndesmotic injuries: prospective comparison of knotless suture-button fixation and syndesmotic screw fixation. J Clin Med. 2022;11:2524.
- [Google Scholar]
- Syndesmosis fixation in supination-external rotation ankle fractures. long-term results of a prospective randomised study. Foot Ankle Surg. 2022;28:229-234.
- [Google Scholar]
- Comparative CT study on syndesmosis mobility after static or dynamic fixation for ankle fractures with syndesmotic rupture: a pilot study. Arch Bone Jt Surg. 2022;10:702-711.
- [Google Scholar]
- Comparison the treatment of anterior inferior tibiofibular ligament anatomical repair and syndesmosis screw fixation for syndesmotic injuries in ankle fracture. BMC Surg. 2023;23:80.
- [Google Scholar]
- Suture-button syndesmosis fixation: accelerated rehabilitation and improved outcomes. Clin Orthop Relat Res. 2005;431:207-212.
- [Google Scholar]
- A comparison of double single suture-button fixation, suture-button fixation, and screw fixation for ankle syndesmosis injury. Medicine (Baltim). 2021;100
- [Google Scholar]
- Radiographic evaluation of syndesmosis stabilisation using the TightRope system versus syndesmotic screw fixation for the management of ankle fractures with a syndesmotic injury. Cureus. 2023;15
- [Google Scholar]
- Comparison of screw fixation with elastic fixation methods in the treatment of syndesmosis injuries in ankle fractures. Injury. 2015;46:S19-S23.
- [Google Scholar]
- Syndesmotic fixation in supination-external rotation ankle fractures: a prospective randomized study. Foot Ankle Int. 2014;35:988-995.
- [Google Scholar]
- Fixation of ankle syndesmotic injuries: comparison of TightRope fixation and syndesmotic screw fixation for accuracy of syndesmotic reduction. Am J Sports Med. 2012;40:2828-2835.
- [Google Scholar]
- The effect of stabilization procedures on sports discipline and performance level in non-elite athletes after acute syndesmotic injury: a prospective randomized trial. J Clin Med. 2022;11:4609.
- [Google Scholar]
- Tricortical versus quadricortical syndesmosis fixation in ankle fractures: a prospective, randomized study comparing two methods of syndesmosis fixation. J Orthop Trauma. 2004;18:331-337.
- [Google Scholar]
- No difference in functional and radiographic results 8.4 years after quadricortical compared with tricortical syndesmosis fixation in ankle fractures. J Orthop Trauma. 2010;24:17-23.
- [Google Scholar]
- Post-treatment functional outcomes of distal tibiofibular syndesmosis injuries with varying duration and method of stabilization. J Foot Ankle Surg. 2024;63:735-741.
- [Google Scholar]
- Effectiveness comparison of flexible fixation and rigid fixation in treatment of ankle pronation-external rotation fractures with distal tibiofibular syndesmosis. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2017;31(7):820-824.
- [Google Scholar]
- Canadian orthopaedic Trauma society; improved reduction of the tibiofibular syndesmosis with TightRope compared with screw fixation: results of a randomized controlled study. J Orthop Trauma. 2019;33:531-537.
- [Google Scholar]
- A new type of elastic fixation, using an encircling and binding technique, for tibiofibular syndesmosis stabilization: comparison to traditional cortical screw fixation. J Orthop Surg Res. 2023;18:269.
- [Google Scholar]
- Dynamic fixation versus static screw fixation for syndesmosis injuries in pronation external rotation ankle fractures: a retrospective case control study. Malays Orthop J. 2023;17:48-58.
- [Google Scholar]
- “Flexible nature of fixation” in syndesmotic stabilization of the inferior tibiofibular joint affects the radiological reduction outcome. Int Orthop. 2022;46:2649-2657.
- [Google Scholar]
- [Translated article] A randomised clinical trial comparing screws and the TighRope® knotless system in the treatment of acute injuries of syndesmosis. Rev Esp Cir Ortop Traumatol. 2022;66:T73-T81.
- [Google Scholar]
- Better outcome for suture button compared with single syndesmotic screw for syndesmosis injury: five-year results of a randomized controlled trial. Bone Joint Lett J. 2020;102-B:212-219.
- [Google Scholar]
- A prospective, randomised trial comparing the use of absorbable and metallic screws in the fixation of distal tibiofibular syndesmosis injuries: mid-term follow-up. Bone Joint Lett J. 2014;96-B:548-554.
- [Google Scholar]
- Fixation of syndesmotic ruptures in 38 patients with a malleolar fracture: a randomized study comparing a metallic and a bioabsorbable screw. J Orthop Trauma. 2005;19:392-395.
- [Google Scholar]
- Removal of the syndesmotic screw after the surgical treatment of a fracture of the ankle in adult patients does not affect one-year outcomes: a randomised controlled trial. Bone Joint Lett J. 2014;96-B:1699-1705.
- [Google Scholar]
- Posterior malleolar stabilization of syndesmotic injuries is equivalent to screw fixation. Clin Orthop Relat Res. 2010;468:1129-1135.
- [Google Scholar]
- Anterior-inferior tibiofibular ligament anatomical repair and augmentation versus trans-syndesmosis screw fixation for the syndesmotic instability in external-rotation type ankle fracture with posterior malleolus involvement: a prospective and comparative study. Injury. 2016;47:1574-1580.
- [Google Scholar]
- Evaluation of reduction accuracy of suture-button and screw fixation techniques for syndesmotic injuries. Foot Ankle Int. 2016;37:1317-1325.
- [Google Scholar]
- Novel elastic syndesmosis hook plate fixation versus routine screw fixation for syndesmosis injury. J Foot Ankle Surg. 2018;57:65-68.
- [Google Scholar]
- Tibiotalar joint dynamics: indications for the syndesmotic screw--a cadaver study. Foot Ankle. 1993;14:153-158.
- [Google Scholar]
- The effects of fibular and talar displacement on joint contact areas about the ankle. Orthop Rev. 1992;21:741-744.
- [Google Scholar]
- The functional consequence of syndesmotic joint malreduction at a minimum 2-year follow-up. J Orthop Trauma. 2012;26:439-443.
- [Google Scholar]
- Radiographic outcomes of flexible and rigid fixation techniques of syndesmotic injuries across various body mass indices: a retrospective analysis. J Foot Ankle Surg. 2025;64(3):248-252.
- [Google Scholar]

